Hyderabad based NATCO Pharma Limited has recorded consolidated total revenue of INR 513.0 Crore for the Third quarter ended on 31st December, 2019, as ... Feb 18
The bulk drugs (API) segment contributed around 58 per cent to the company’s total turnover in Q3' FY 2019-20. The company’s expanding ... Feb 18
Revenue from operations stood at Rs 538.18 crore for the quarter under consideration. ... Feb 15
Consolidated Net Profit rises by 64% to Rs. 1,908.39 Mn. in Q3 FY 2019-20. Consolidated EBITDA rises by 1.2% to Rs. ... Feb 15
The company’s board has declared an interim dividend of Rs 5 per share, Ipca Laboratories said. Shares of Ipca Laboratories were trading at Rs ... Feb 13
Company is building a strong portfolio in lifestyle and chronic segment especially in women healthcare and dermatology to complement its strong presence in acute segment... Feb 13
During the quarter, India branded formulation sales grew by 10.6% compared to Q3 FY2019.... Feb 10
Zydus Cadila's net profit excluding exceptional items for the quarter was up 18% q-o-q to Rs. 375 crores.... Feb 07
Sun Pharma reports Q3FY20 results Q3 Gross Sales at Rs. 8,039 crores Q3 Net Profit at Rs. 914 crores ... Feb 07
Robust growth in US markets helps Cipla to boost Q3 performance... Feb 06
Strong Q3 numbers for Dr Reddy's... Jan 30
Strong Q3 performance from Strides Pharma... Jan 30
-Advertisements-
.jpeg)
Monday, March 31, 2025
_edit.jpg)
.jpeg)
.jpg)
.png){kind=logo}
.jpg)
